Note: Ingredients listed on restricted chemical lists
EC/CAS
231-633-2/7664-38-2
Name of the chemical
phosphoric acid
Concentration
=85
General Information
Revision date
2022-10-08
Product name
Phosphoric acid
CAS No.
7664-38-2
REACH No
is
1.2.1 Relevant identified uses
Laboratory reagents, not for food and drug, used as pharma excipient
Emergency telephone
+91 - 2717 - 616 717
Icons in SDS
Company Information
company name
Finar Limited
e-mail address of the competent person responsible for the Safety Data Sheet
safety.finar@aceto.com, info.finar@aceto.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H290, H302, H314, H318
Hazard statements
Code
Statements
H290
May be corrosive to metals
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H290 May be corrosive to metals. H302 Harmful if swallowed. H314 Causes severe skin burns and eye damage.
Prevention
P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P301 + P330 + P331 IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P305 + P351 + P338 + P310 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/doctor.
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Corrosive to metals (Category 1), H290 Acute toxicity, Oral (Category 4), H302 Skin corrosion (Sub-category 1B), H314 Serious eye damage (Category 1), H318 For the full text of the H-Statements mentioned in this Section, see Section 16.